XML 48 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2015
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following tables summarize the changes in Level 3 assets and the gains and losses included in earnings for the year ended December 31, 2015:

Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
 
 
 
 
 
(in thousands)
 
 
Royalty Rights
- At Fair Value
December 31, 2014
 
 
$
259,244

 
 
 
 
 
 
 
 
Transfer into Level 3
 
 

 
Total net change in fair value for the period
 
 
 
 
 
Change in fair value of royalty rights - at fair value
$
68,367

 
 
 
Proceeds from royalty rights - at fair value
$
(43,407
)
 
 
 
 
Total net change in fair value for the period
 
 
24,960

 
Purchases, issues, sales, and settlements
 
 
 
 
 
Purchases
 
 
115,000

 
 
 
 
 
 
 
Ending Balance at December 31, 2015
 
 
$
399,204

Schedule of fair value of financial instruments measured on recurring basis

 
 
December 31, 2015
 
December 31, 2014
(In thousands)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Financial assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
 
$
94,801

 
$

 
$

 
$
94,801

 
$
221,792

 
$

 
$

 
$
221,792

Corporate securities
 

 
1,469

 

 
1,469

 

 
2,310

 

 
2,310

Foreign currency hedge contracts
 

 
2,802

 

 
2,802

 

 
4,069

 

 
4,069

Warrants
 

 
984

 

 
984

 

 

 

 

Royalty rights - at fair value
 

 

 
399,204

 
399,204

 

 

 
259,244

 
259,244

Total
 
$
94,801

 
$
5,255

 
$
399,204

 
$
499,260

 
$
221,792

 
$
6,379

 
$
259,244

 
$
487,415

Schedule of fair value of assets and liabilities not subject to fair value recognition by level within the valuation hierarchy

 
 
December 31, 2015
 
December 31, 2014
 
 
Carrying Value
 
Level 2
 
Level 3
 
Carrying Value
 
Level 2
 
Level 3
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Wellstat Diagnostics note receivable
 
$
50,191

 
$

 
$
55,970

 
$
50,191

 
$

 
$
50,191

Hyperion note receivable
 
1,200

 

 
1,200

 
1,200

 

 
1,200

Avinger note receivable
 

 

 

 
20,611

 

 
20,760

LENSAR note receivable
 
42,271

 

 
42,618

 
39,668

 

 
40,451

Direct Flow Medical note receivable
 
51,852

 

 
51,992

 
50,397

 

 
49,940

Paradigm Spine note receivable
 
53,973

 

 
54,250

 
49,571

 

 
50,125

kaléo note receivable
 
146,778

 

 
146,789

 
151,574

 

 
151,073

CareView note receivable
 
18,640

 

 
19,495

 

 

 

Total
 
$
364,905

 
$

 
$
372,314

 
$
363,212

 
$

 
$
363,740

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Series 2012 Notes
 
$

 
$

 
$

 
$
22,261

 
$
33,506

 
$

May 2015 Notes
 

 

 

 
153,235

 
205,534

 

February 2018 Notes
 
232,835

 

 
197,946

 
276,228

 
289,665

 

Term loan
 
24,966

 

 
25,000

 

 

 

Total
 
$
257,801

 
$

 
$
222,946

 
$
451,724

 
$
528,705

 
$